"Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a multi-center, randomized, double-blind, placebo controlled trial (GWPCARE4) (S21.001)." Neurology
88.16 Supplement
(2017):
S21.001.
Web. 27 Jan. 2022.
Advertisement